EverSource Wealth Advisors, LLC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1710537
BIRMINGHAM, AL
Position in TRVI
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$64,378
+$64,247 QoQ
Shares Held
3,452
+31281.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#175
of 216 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EverSource Wealth Advisors, LLC holds $15,234,841 across 258 Biotechnology names. TRVI ranks #32 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
110,689 | $6,036,977 | |
| 2 | INCY |
Incyte Corp
|
9,004 | $1,020,689 | |
| 3 | RPRX |
Royalty Pharma plc
|
13,228 | $741,689 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,357 | $674,058 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
912 | $568,663 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
16,556 | $568,200 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,321 | $452,739 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,146 | $324,502 |
All Filings in TRVI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,378 | 3,452 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $131 | 11 | Shares | Sole | 2026-05-18 | |
| 2025-06-30 | $5 | 1 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $62 | 10 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||